The Cancer Research UK Stratified Medicine Programme as a model for delivering personalised cancer care.
Maria Antonietta CeroneTara C MillsRowena SharpeDavid McBrideMoira MacDonaldSuzanne MacMahonHood MugalaasiPauline RehalAlessandro RettinoHelen RobertsMark RossDonald Edward WhiteJohn PedenJanette RawlinsonSteffan N HoSimon HollingsworthSanjay PopatGary M MiddletonPeter JohnsonCharles Swantonnull nullPublished in: British journal of cancer (2023)
Genomic screening is routinely used to guide the treatment of cancer patients in many countries. However, several multi-layered factors make this effort difficult to deliver within a clinically relevant timeframe. Here we share the learnings from the CRUK-funded Stratified Medicine Programme for advanced NSCLC patients, which could be useful to better plan future studies.
Keyphrases
- end stage renal disease
- chronic kidney disease
- small cell lung cancer
- ejection fraction
- newly diagnosed
- peritoneal dialysis
- prognostic factors
- papillary thyroid
- clinical trial
- gene expression
- squamous cell carcinoma
- gold nanoparticles
- dna methylation
- advanced non small cell lung cancer
- reduced graphene oxide
- childhood cancer
- patient reported